The recent approval in 2015 of Radiesse for injection into the hand by the FDA has spurred an increase in interest among patients and clinicians in nonsurgical hand rejuvenation using fillers. Application of the same techniques used to treat the face to the dorsum of the hands does not account for the unique nature of the skin and underlying anatomy, and can lead to suboptimal outcomes and an increased risk of adverse events such as the formation of nodules. Here, the authors discuss dilution strategies and injection techniques for hand rejuvenation using Radiesse for optimal patient safety and aesthetic outcomes.
Just like the face, the hands are a highly visible part of the body subject to visible aging through sun exposure, environmental conditions such as smoking, and volume depletion. 1 Atrophy within fat deposits, coupled with the thinning of the overlying skin, causes underlying tendons, bones, and veins to become visible. The progressive visibility of these structures are at the root of why the appearance of the hands are a reliable indicator of age. 2 The hands age at approximately the same rate as the face, and many patients already receiving facial injections seek hand rejuvenation to balance the more youthful appearance of their face with younger looking hands.
Though hand rejuvenation with injectable fillers has dramatically increased in popularity over the past 10 years, 3 only since 2015 has there been a Food and Drug Administration (FDA)-approved agent available for treatment of this anatomical area. 4 Prior to the approval of hydroxylapatite microspheres in carboxymethyl cellulose carrier gel (Radiesse [CaHA] ; Merz North America, Inc., Raleigh, NC) for hand rejuvenation, fat grafting, 5 and off-label injection of fillers approved for treatment of wrinkles and folds in the face were the only available approaches for revolumization. The first injection-based technique for hand rejuvenation was a bolus injection of an autologous fat graft detailed by Fournier in 1988, 6 and this technique was further refined using multiple, smaller bolus injection sites by Coleman in 2002. 5 However, hyaluronic acid (HA) fillers quickly displaced fat as the go-to agent for hand rejuvenation due to ease of use and more consistent results. 2 The approval of Radiesse marked not only the very first approval by the FDA of a filler for hand rejuvenation, but also the first approval of an agent that can improve the quality of skin through stimulation of collagen in the hand. Though availability of an approved agent for the hands is an important first step, there remains a need for an effective, evidence-based injection technique that maximizes both patient safety and clinical outcomes. Indeed, the increase in interest that accompanies approval must be met with development of expertise. The authors of this publication have treated over 75 patients, and have been using Radiesse for hand rejuvenation for over 13 years. Further, they have long been proponents of using cannula for safer hand rejuvenation with better outcomes. 7, 8 Overall, current treatment indications on the FDA label are at odds with both patient safety and high quality outcomes that are achievable with Radiesse. 4 The recommended injection amounts per hand are disconnected with the clinical goals of patients: rejuvenation to disguise veins, tendons, and bony projections requires far less CaHA than called for on the label. Another aspect of the currently recommended treatment protocol that must be addressed is the mode by which the product is injected. Multiple bolus injections with a needle require massaging and multiple ports of injection, increasing the risk of adverse events, such as ecchymosis, and the likelihood that the product will envelop tendon sheaths. 1 Here, the authors assert that in order to maximize patient safety and aesthetic outcomes while minimizing adverse events such as nodule formation and bruising, a cannula should be used for a finely controlled delivery of Radiesse. Finally, though the FDA labeling of Radiesse for hand rejuvenation indicates that Radiesse may be injected without prior dilution, the clinical expertise of the authors indicates that Radiesse must be appropriately diluted, at a high dilution. Here, the authors discuss their strategies for hand rejuvenation using Radiesse and propose injection techniques for optimal clinical outcomes and patient safety.
Cannula Use for Controlled Placement in the Subdermal Plane
Work exploring optimal technique for Radiesse injection in hand rejuvenation utilized cadaver-based studies to differentiate a bolus injection with a needle followed by massage from a retrograde injection and threading technique with a cannula. 1 This study clearly shows that product placed with a bolus injection is found outside of the subdermal plane and can end up around the tendon sheaths. This is clearly an undesirable outcome, and increases the risk of adverse events in the patient. In contrast, product placed with a cannula in the fibrous tissue of the subdermal plane allows the injector to avoid resident tendons and vasculature while placing the product where it is needed, rather than relying on massage. The facility with which the entire dorsum of the hand can be reached, as well as the ease with which dorsal veins may be safely moved with the blunt cannula are demonstrated in a video included as part of this supplement (Video 1). The fine control achievable with a cannula minimizes trauma associated with massaging by allowing more controlled product placement and prevents CaHA from contacting the tendon sheaths or compressing vasculature.
Cannula use for more controlled product placement is further supported by anatomical studies of the fibrous space underneath the dermis. Study of the fascial compartment anatomy in the dorsum of the hand show that there are barriers to spread that make a single or even multiple bolus injection-based technique difficult for achieving even product distribution. 9 Though there is variation in compartmentalization among individuals, these barriers to spread are invariably present. While these barriers limit spread following a bolus injection, a cannula can be passed into appropriate anatomic regions. When considering the compartmentalization of the subdermal plane, a cannula not only allows for controlled deposition of material, but permits a single injection port for treatment of the entire dorsum of the hand.
Recommendation: A Single Proximal Injection Site With a Cannula Provides Optimal Results
While the preliminary anatomical study discussed above suggests a retrograde injection with scraping in the distal portion of the hand, 1 the authors recommend instead a single proximal injection into the subdermal plane with a cannula. Product distribution achievable with a 22-gauge 70 to 90 mm cannula (depending on patient hand size) when placed in a single, proximal injection site can reach all areas of the dorsum of the hand, even the metacarpal phalangeal area (Figures 1-2, Video 1) . The single injection port maximizes patient safety and comfort, and proximal insertion of the cannula allows for product placement that mirrors the radial distribution of the hand's tendons and permits a more controlled injection into the more adherent distal portions of the hand. This is especially important for placement of Raiesse, where results may be appreciated 1 year postinjection (Figure 1) . 
Recommendation: Technique for Hand Rejuvenation With a Cannula
In order to achieve the optimal results possible using a cannula rather than a needle for Radiesse injection, proper technique must be used. A video demonstrating hand augmentation with a blunt cannula is presented here (Video 1). First, topical anesthetic may be applied to the proximal puncture site in order to minimize patient discomfort. A puncture is made with a needle that is of slightly larger caliber that the cannula itself. The cannula is then inserted through the puncture site, and the cannula threaded through the potential space for product deposition. The cannula can reach all the way to the metacarpal phalangeal joint area, allowing for precise product placement. One advantage of using a blunt cannula is that dorsal veins may be pushed to the side without risk of puncture, permitting precise product placement over the entire area of the dorsum of the hand. Following product placement to disguise depression, veins, and extensor tendons, rigorous massage with lotion ensures even product distribution.
The Importance of Appropriate Dilution
Though the FDA labeling of Radiesse for hand rejuvenation states that undiluted Radiesse may be injected directly into the hand, this is a reflection of an underdeveloped application of techniques that may be appropriate for injection in certain regions of the face (ie, the chin) to an anatomically distinct region, in this case the hands. When undiluted Radiesse is injected into the hands with a needle, the additive effect of these suboptimal treatment strategies can lead to unnecessary bruising. Here, the authors propose an appropriate dilution for Radiesse tailored specifically to rejuvenation of the dorsum of the hand. In the clinical experience of the authors, appropriate dilution of Radiesse, coupled with an effective injection technique with a cannula (Video 1) largely obviates the incidence of swelling and minimizes bruising. This is in stark contrast to the rate of bruising and swelling that injectors are instructed to anticipate in workshops or trainings where the product is injected without being diluted. Indeed, the incidence of bruising in the clinical trials for Radiesse was 73%, 4 while the authors of this publication very rarely see bruising in their own practices. In the experience of the primary author, of 35 patients treated, 0 have developed hematomas, and 2 reported slight ecchymosis at the cannula entry site ( Figure 2B) .
In elderly patients, sufficient dilution is especially important for avoiding senile purpura. In these patients, the atrophy in the hand's skin demands a gentleness approaching that required when treating a patient's eyelids. Otherwise, an occasional patient will have some postinjection hand sensitivity that is easily resolvable with nonsteroidal anti-inflammatory drugs (NSAIDs). Appropriate dilution also minimizes the incidence of nodules beyond the comparatively low incidence reported. 2 In discussing dilution recommendations, the authors consider the goals of treatment as well as the age of the patient and condition of their skin.
Recommendations for Radiesse Dilution
For a single hand rejuvenation treatment, the average patient requires between 0.75 and 1.0 cc of Radiesse diluted 1:1 v/v with a 1% lidocaine solution, per hand. Even when diluted, Radiesse maintains a comparatively high opacity, a quality of particular importance for patients with atrophic skin. In some less frequent instances, a less dilute product can offer additional opacity or more dramatic revolumization, if the need is dictated by the state of the patient's hands. In these cases, dilution may range from 1:1 (Radiesse: 1% lidocaine) and 2:1 (Radiesse: 1% lidocaine). None of the authors recommend using Radiesse that is less dilute than 2:1, and recommend against the use of undiluted Radiesse in the hands. Failure to properly dilute the product raises the likelihood of nodule formation. Regardless of the dilution used, injection with a cannula is critical for both simplifying the technique itself and for maximizing patient safety and clinical results.
Recommendations for Radiesse Volume
For patients seeking hand rejuvenation, the goal is to camouflage visible tendons and veins and minimize depressions and the profile of visible bones. When using Radiesse to achieve these goals, the treatment provides not only immediate improvement, but has the added benefit of revitalizing and activating the skin through collagen stimulation, an aspect that is especially important for patients with atrophic skin. In the experience of the authors, the average patient requires between 0.5 and 1.5 cc of Radiesse (diluted 1:1 or 2:1 with 1% lidocaine for a total injection volume of between 1 and 2.25 cc) per hand. This translates into usage of between1 and 3 × 1.5 mL syringes of product (to be appropriately diluted), for both hands. Occasionally, patients require additional Radiesse to sufficiently fill in depressions or disguise tendons and veins, but rarely to the degree specified by the label. Indeed, the volume of product recommended on the label is geared towards "filling" the hands, rather than disguising depressions that may give away a patient's age.
Postprocedure Care
Placement of appropriately diluted Radiesse with a cannula eliminates much of the bruising and discomfort noted in the Radiesse clinical trials. 4 Dilution with a 1% lidocaine solution further alleviates any discomfort, making injection virtually painless. Patients need not sit on their hands as they are instructed to do with other fillers or bolus injections, as the material has been placed exactly where it needs to be with a cannula. Application of ice directly after the treatment is generally sufficient to reduce swelling, and patients generally do not require additional applications of ice following the treatment. In the rare case of postinjection tenderness, patients can be offered steroids or NSAIDs, and these cases are universally resolvable. Overall, the minimal bruising that accompanies proper dilution and cannula use not only improves patient safety by limiting the spread of CaHA to the appropriate plane, but increases patient satisfaction with the procedure.
DISCUSSION
In the experience of the authors, the outcomes of hand rejuvenation with Radiesse are significantly improved with both appropriate dilution of the product, as well as placement with a blunt cannula. This experience is consistent with both anatomical studies comparing product placement with a needle vs cannula, 1 as well as other outcomes observed with a blunt cannula study on hand rejuvenation with lipotransfer, which shows that cannula use in both the superficial and deep fat compartments is safe. 10, 11 While additional research may be needed to further quantify the advantages of proper dilution and cannula use for optimal outcomes, the technique presented here (Video 1) presents an approach that has worked well in the hands of the authors and is supported by anatomical and practical research.
CONCLUSION
Following approval of new fillers, clinicians are faced with the task of identifying the appropriate patient niche, developing handling technique, and determining the best way to achieve optimal results. As FDA-recommended procedures are universally difficult to apply, the dissemination of proper technique and treatment protocol gleaned through extensive experience is of particular importance. The authors have considerable experience using Radiesse for hand rejuvenation and have applied their collective expertise to make treatment recommendations for Radiesse that better suit patient treatment goals and maximize both safety and clinical results. Injecting the product with a cannula improves the safety of the product beyond that achievable with a single bolus injection and ensures that the product is correctly placed and injecting appropriate volumes of adequately diluted product minimizes bruising while meeting patient aesthetic goals. When clinicians include the above described guidelines in practice, Radiesse easily emerges as one of the preferred treatments for hand rejuvenation.
